Globus Medical, Inc.
General ticker "GMED" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $10.1B (TTM average)
Globus Medical, Inc. follows the US Stock Market performance with the rate: 22.2%.
Estimated limits based on current volatility of 1.4%: low 79.86$, high 82.10$
Factors to consider:
- Total employees count: 5300 as of 2024
- US accounted for 79.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Regulatory and compliance, Litigation risks, Supply chain disruptions, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [70.76$, 99.88$]
- 2026-12-31 to 2027-12-31 estimated range: [71.73$, 102.08$]
Financial Metrics affecting the GMED estimates:
- Negative: with PPE of 22.1 at the end of fiscal year the price was high
- Positive: 7.80 < Operating profit margin, % of 16.33
- Positive: Return on assets ratio (scaled to [-100,100]) of 9.21 > 6.06
- Positive: Shareholder equity ratio, % of 86.24 > 63.63
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of -0.25 <= 0
- Positive: -4.49 < Investing cash flow per share per price, % of -2.97
- Negative: negative Industry operating cash flow (median)
Short-term GMED quotes
Long-term GMED plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,568.48MM | $2,519.36MM | $2,938.93MM |
| Operating Expenses | $1,435.33MM | $2,353.36MM | $2,459.11MM |
| Operating Income | $133.14MM | $165.99MM | $479.82MM |
| Non-Operating Income | $32.25MM | $-45.27MM | $125.25MM |
| R&D Expense | $124.01MM | $163.75MM | $147.25MM |
| Income(Loss) | $165.39MM | $120.72MM | $605.07MM |
| Taxes | $42.52MM | $17.74MM | $67.20MM |
| Net Income(Loss)* | $122.87MM | $102.98MM | $537.87MM |
| Stockholders Equity | $3,997.96MM | $4,177.33MM | $4,573.25MM |
| Inventory | $848.13MM | $659.23MM | $759.28MM |
| Assets | $5,086.08MM | $5,251.75MM | $5,302.76MM |
| Operating Cash Flow | $243.50MM | $520.64MM | $753.45MM |
| Capital expenditure | $78.27MM | $115.43MM | $164.68MM |
| Investing Cash Flow | $302.97MM | $-176.05MM | $-355.01MM |
| Financing Cash Flow | $-231.82MM | $-27.70MM | $-679.16MM |
| Earnings Per Share** | $1.09 | $0.76 | $3.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.